RIP1 Cleavage in the Kinase Domain Regulates TRAIL-Induced NF-κB Activation and Lymphoma Survival.
about
The Janus Face of Death Receptor Signaling during Tumor ImmunoeditingCationic PEGylated liposomes incorporating an antimicrobial peptide tilapia hepcidin 2-3: an adjuvant of epirubicin to overcome multidrug resistance in cervical cancer cells.Cell Death Pathways: a Novel Therapeutic Approach for Neuroscientists.Inhibition of caspases primes colon cancer cells for 5-fluorouracil-induced TNF-α-dependent necroptosis driven by RIP1 kinase and NF-κB.Developing TRAIL/TRAIL death receptor-based cancer therapies.Targeting CAND1 promotes caspase-8/RIP1-dependent apoptosis in liver cancer cells.
P2860
RIP1 Cleavage in the Kinase Domain Regulates TRAIL-Induced NF-κB Activation and Lymphoma Survival.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
RIP1 Cleavage in the Kinase Do ...... ivation and Lymphoma Survival.
@ast
RIP1 Cleavage in the Kinase Do ...... ivation and Lymphoma Survival.
@en
type
label
RIP1 Cleavage in the Kinase Do ...... ivation and Lymphoma Survival.
@ast
RIP1 Cleavage in the Kinase Do ...... ivation and Lymphoma Survival.
@en
prefLabel
RIP1 Cleavage in the Kinase Do ...... ivation and Lymphoma Survival.
@ast
RIP1 Cleavage in the Kinase Do ...... ivation and Lymphoma Survival.
@en
P2093
P2860
P356
P1476
RIP1 Cleavage in the Kinase Do ...... ivation and Lymphoma Survival.
@en
P2093
Ken Blackwell
Laiqun Zhang
Lauren M Workman
Marshall R Pope
Siegfried Janz
P2860
P304
P356
10.1128/MCB.00692-15
P407
P577
2015-07-20T00:00:00Z